TrialAssure Launches First-in-Class Document Anonymization Tool Using Machine Learning and Artificial Intelligence to Protect Patient Data

TrialAssure– a leading, global software company advancing clinical trial transparency tools – announced today the limited release of ANONYMIZE R, a first-in-class document anonymization software that uses machine learning, natural language processing, and artificial intelligence (AI) to protect patient privacy by automatically finding and removing personal information from text. The announcement was made during the American Medical Writer’s Association (AMWA) annual conference in San Diego, California.

“ANONYMIZE R solves this problem by allowing users to apply the same techniques to all clinical trial outputs, taking a holistic approach that ensures both consistency and efficiency. Aligning with regulatory guidelines, it drives its effectiveness with sophisticated, modern technology – replacing the age-old manual redaction process.”

Read More: AiThority Interview with Rob Fox, CTO at HG Insights

TrialAssure’s newest addition to its transparency suite, ANONYMIZE R, is intended for reports and documents, and it gives users the ability to apply rules that substitute information, reducing the possibility of a reader identifying a clinical trial patient. Using a powerful risk algorithm builder, ANONYMIZE R generates a re-identification risk score and produces a risk assessment report, ensuring that the anonymized document meets an acceptable risk threshold.

Read More: New Virtual Reality Training From Tork Is a Game Changer for Improving Hand Hygiene Compliance

“When clinical trial data and documents are released to the public or research community, they are often prepared through different channels and at different times – leading to inconsistencies in the anonymization process. These inconsistencies limit the value of the information, because they reduce the ability for other researchers to effectively analyze all the available data,” said Zach Weingarden, Product Solutions Manager, TrialAssure. “ANONYMIZE R solves this problem by allowing users to apply the same techniques to all clinical trial outputs, taking a holistic approach that ensures both consistency and efficiency. Aligning with regulatory guidelines, it drives its effectiveness with sophisticated, modern technology – replacing the age-old manual redaction process.”

Read More: AiThority Interview with Rob Fox, CTO at HG Insights